Clinical Trial: Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Management of Hospitalized Respiratory Syncytial Virus (RSV) Infected Patients in the Neonatal Intensive Care Unit (NICU) and Control of Epidemics; TurkNICU-RSV Study: A Multicentric, Prospective Tria

Brief Summary: The principle purpose of this multicenter trial is to determine the definition, timing and the percentage of nosocomial RSV epidemics throughout Turkey. In addition, secondary purpose of the trial is to determine the prevention strategies of further spread of Respiratory Syncytial Virus (RSV) in the neonatal intensive care unit (NICU).

Detailed Summary:
Sponsor: Ankara University

Current Primary Outcome: Hospitalized Respiratory Syncytial Virus infected Newborn in the Neonatal Intensive Care Units, and its relation with possible epidemics. [ Time Frame: Patients will be followed during hospitalization, with expected average of 3 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Mortality [ Time Frame: Patients will be followed during hospitalization, with expected average of 3 weeks ]

mortality related to RSV infection and epidemics


Original Secondary Outcome: Same as current

Information By: Ankara University

Dates:
Date Received: July 26, 2013
Date Started: September 2013
Date Completion:
Last Updated: January 13, 2015
Last Verified: January 2015